Targeted Therapies in Oncology
April 2016
Volume: 5
Issue: 3
March 2016
Volume: 6
Issue: 2
January 2016
Volume: 5
Issue: 1
November 2015
Volume: 4
Issue: 8
October 2015
Volume: 4
Issue: 7
September 2015
Volume: 4
Issue: 6
July 2015
Volume: 4
Issue: 5
May 2015
Volume: 4
Issue: 4
April 2015
Volume: 4
Issue: 2
November 2014
Volume: 3
Issue: 6
September 2014
Volume: 3
Issue: 5
July 2014
Volume: 3
Issue: 4
May 2014
Volume: 3
Issue: 3
March 2014
Volume: 3
Issue: 2
January 2014
Volume: 3
Issue: 1
November 2013
Volume: 2
Issue: 6
September 2013
Volume: 2
Issue: 5
July 2013
Volume: 2
Issue: 4
May 2013
Volume: 2
Issue: 3
March 2013
Volume: 2
Issue: 2
January 2013
Volume: 2
Issue: 1
November 2012
Volume: 1
Issue: 4
September 2012
Volume: 1
Issue: 3
June 2012
Volume: 1
Issue: 2
March 2012
Volume: 1
Issue: 1
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Subcutaneous Amivantamab for EGFR-Mutated NSCLC Indications
2
Long-Term ECHO Data Support Concurrent Acalabrutinib/BR in MCL
3
Pelareorep Offers Promise in Second-Line KRAS-Mutant Metastatic CRC
4
FDA Grants Regular Approval to Rucaparib for BRCA-Mutated mCRPC
5